Urinary glycosaminoglycans in normal subjects and patients with stones

T. I S Hwang, G. M. Preminger, J. Poindexter, C. Y C Pak

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Urinary glycosaminoglycans are thought to be macromolecular inhibitors of calcium stone formation. The 24-hour excretion of urinary glycosaminoglycans was measured quantitatively in 24 normal subjects and 206 patients with different etiologies of stone disease. In both groups a positive correlation was found between urinary glycosaminoglycans and total urinary volume and urinary sulfate. In normal subjects total urinary volume was r equals 0.716, p less than 0.001 and urinary sulfate was r equals 0.813, p less than 0.001, while in patients with stones these values were r equals 0.338, p less than 0.001 and r equals 0.326, p less than 0.001, respectively. The only significant difference in excretion of urinary glycosaminoglycans between the groups was found in the subgroup of patients with type I absorptive hypercalciuria. The type I absorptive hypercalciuria value of 33.4 ± 14.9 mg per day in patients with stones was significantly higher than the 25.8 ± 8.3 mg per day detected in normal subjects (p less than 0.05). Urinary glycosaminoglycan excretion in all other subgroups of nephrolithiasis as well as in a combined group of all patients with stones showed no significant differnce when compared to that of normal subjeccts. Thus, no major quantitative relationship could be demonstrated between urinary glycosaminoglycan excretion and calcium stone formation in this study.

Original languageEnglish (US)
Pages (from-to)995-997
Number of pages3
JournalJournal of Urology
Volume139
Issue number5
StatePublished - 1988

Fingerprint

Glycosaminoglycans
Hypercalciuria
Sulfates
Calcium
Nephrolithiasis

ASJC Scopus subject areas

  • Urology

Cite this

Hwang, T. I. S., Preminger, G. M., Poindexter, J., & Pak, C. Y. C. (1988). Urinary glycosaminoglycans in normal subjects and patients with stones. Journal of Urology, 139(5), 995-997.

Urinary glycosaminoglycans in normal subjects and patients with stones. / Hwang, T. I S; Preminger, G. M.; Poindexter, J.; Pak, C. Y C.

In: Journal of Urology, Vol. 139, No. 5, 1988, p. 995-997.

Research output: Contribution to journalArticle

Hwang, TIS, Preminger, GM, Poindexter, J & Pak, CYC 1988, 'Urinary glycosaminoglycans in normal subjects and patients with stones', Journal of Urology, vol. 139, no. 5, pp. 995-997.
Hwang, T. I S ; Preminger, G. M. ; Poindexter, J. ; Pak, C. Y C. / Urinary glycosaminoglycans in normal subjects and patients with stones. In: Journal of Urology. 1988 ; Vol. 139, No. 5. pp. 995-997.
@article{87290e9f672b455aa1300c8484628d6a,
title = "Urinary glycosaminoglycans in normal subjects and patients with stones",
abstract = "Urinary glycosaminoglycans are thought to be macromolecular inhibitors of calcium stone formation. The 24-hour excretion of urinary glycosaminoglycans was measured quantitatively in 24 normal subjects and 206 patients with different etiologies of stone disease. In both groups a positive correlation was found between urinary glycosaminoglycans and total urinary volume and urinary sulfate. In normal subjects total urinary volume was r equals 0.716, p less than 0.001 and urinary sulfate was r equals 0.813, p less than 0.001, while in patients with stones these values were r equals 0.338, p less than 0.001 and r equals 0.326, p less than 0.001, respectively. The only significant difference in excretion of urinary glycosaminoglycans between the groups was found in the subgroup of patients with type I absorptive hypercalciuria. The type I absorptive hypercalciuria value of 33.4 ± 14.9 mg per day in patients with stones was significantly higher than the 25.8 ± 8.3 mg per day detected in normal subjects (p less than 0.05). Urinary glycosaminoglycan excretion in all other subgroups of nephrolithiasis as well as in a combined group of all patients with stones showed no significant differnce when compared to that of normal subjeccts. Thus, no major quantitative relationship could be demonstrated between urinary glycosaminoglycan excretion and calcium stone formation in this study.",
author = "Hwang, {T. I S} and Preminger, {G. M.} and J. Poindexter and Pak, {C. Y C}",
year = "1988",
language = "English (US)",
volume = "139",
pages = "995--997",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Urinary glycosaminoglycans in normal subjects and patients with stones

AU - Hwang, T. I S

AU - Preminger, G. M.

AU - Poindexter, J.

AU - Pak, C. Y C

PY - 1988

Y1 - 1988

N2 - Urinary glycosaminoglycans are thought to be macromolecular inhibitors of calcium stone formation. The 24-hour excretion of urinary glycosaminoglycans was measured quantitatively in 24 normal subjects and 206 patients with different etiologies of stone disease. In both groups a positive correlation was found between urinary glycosaminoglycans and total urinary volume and urinary sulfate. In normal subjects total urinary volume was r equals 0.716, p less than 0.001 and urinary sulfate was r equals 0.813, p less than 0.001, while in patients with stones these values were r equals 0.338, p less than 0.001 and r equals 0.326, p less than 0.001, respectively. The only significant difference in excretion of urinary glycosaminoglycans between the groups was found in the subgroup of patients with type I absorptive hypercalciuria. The type I absorptive hypercalciuria value of 33.4 ± 14.9 mg per day in patients with stones was significantly higher than the 25.8 ± 8.3 mg per day detected in normal subjects (p less than 0.05). Urinary glycosaminoglycan excretion in all other subgroups of nephrolithiasis as well as in a combined group of all patients with stones showed no significant differnce when compared to that of normal subjeccts. Thus, no major quantitative relationship could be demonstrated between urinary glycosaminoglycan excretion and calcium stone formation in this study.

AB - Urinary glycosaminoglycans are thought to be macromolecular inhibitors of calcium stone formation. The 24-hour excretion of urinary glycosaminoglycans was measured quantitatively in 24 normal subjects and 206 patients with different etiologies of stone disease. In both groups a positive correlation was found between urinary glycosaminoglycans and total urinary volume and urinary sulfate. In normal subjects total urinary volume was r equals 0.716, p less than 0.001 and urinary sulfate was r equals 0.813, p less than 0.001, while in patients with stones these values were r equals 0.338, p less than 0.001 and r equals 0.326, p less than 0.001, respectively. The only significant difference in excretion of urinary glycosaminoglycans between the groups was found in the subgroup of patients with type I absorptive hypercalciuria. The type I absorptive hypercalciuria value of 33.4 ± 14.9 mg per day in patients with stones was significantly higher than the 25.8 ± 8.3 mg per day detected in normal subjects (p less than 0.05). Urinary glycosaminoglycan excretion in all other subgroups of nephrolithiasis as well as in a combined group of all patients with stones showed no significant differnce when compared to that of normal subjeccts. Thus, no major quantitative relationship could be demonstrated between urinary glycosaminoglycan excretion and calcium stone formation in this study.

UR - http://www.scopus.com/inward/record.url?scp=0023950103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023950103&partnerID=8YFLogxK

M3 - Article

C2 - 3361677

AN - SCOPUS:0023950103

VL - 139

SP - 995

EP - 997

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -